S. Jeson Sangaralingham

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial”.

B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial

Heart(2020)10.1136/heartjnl-2020-317182

N/A

0.832DataRank · unranked

16 citations

John A. Schirger, S. Jeson Sangaralingham, Yang Chen, John C. Burnett, David O. Hodge +2 more

Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker

Mayo Clinic Proceedings Innovations Quality & Outcomes(2021)10.1016/j.mayocpiqo.2020.10.008

N/A

0DataRank · unranked

7 citations

Yihong Deng, Xiaoxi Yao, Lindsey R. Sangaralingham, Nilay D. Shah, Andrew D. Rule +4 more

Natriuretic peptide pathways in heart failure: further therapeutic possibilities

Cardiovascular Research(2022)10.1093/cvr/cvac125

N/A

0DataRank · unranked

78 citations

Michaela Kühn, Valentina Cannone, Horng H. Chen, John C. Burnett, S. Jeson Sangaralingham

Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators

PNAS Nexus(2024)10.1093/pnasnexus/pgae225

N/A

0DataRank · unranked

2 citations

Satyamaheshwar Peddibhotla, Ye Zheng, Shuchong Pan, Alka Mehta, Dante Moroni +6 more